Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
about
Cellular Immune Responses and Immune Escape Mechanisms in Breast Cancer: Determinants of ImmunotherapyPredicting chemoinsensitivity in breast cancer with 'omics/digital pathology data fusionImmune DNA signature of T-cell infiltration in breast tumor exomes.Pathway-based personalized analysis of breast cancer expression data.Enumerating the gene sets in breast cancer, a "direct" alternative to hierarchical clustering.Improved prognostic classification of breast cancer defined by antagonistic activation patterns of immune response pathway modulesA fuzzy gene expression-based computational approach improves breast cancer prognosticationImmunoglobulin kappa C predicts overall survival in node-negative breast cancer.Prognostic gene network modules in breast cancer hold promise.Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer.Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.Modelling the spatial heterogeneity and molecular correlates of lymphocytic infiltration in triple-negative breast cancer.Intratumoral CD8⁺ cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancerKinome expression profiling and prognosis of basal breast cancersAssessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapyc-Myc dependent expression of pro-apoptotic Bim renders HER2-overexpressing breast cancer cells dependent on anti-apoptotic Mcl-1Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityA clinically relevant gene signature in triple negative and basal-like breast cancerA three-gene model to robustly identify breast cancer molecular subtypesTumor-infiltrating lymphocytes predict response to anthracycline-based chemotherapy in estrogen receptor-negative breast cancer.CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancerSignatures of tumor-immune interactions as biomarkers for breast cancer prognosisTumour-infiltrating FOXP3(+) lymphocytes are associated with cytotoxic immune responses and good clinical outcome in oestrogen receptor-negative breast cancer.A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer.Autoimmune diseases and hypersensitivities improve the prognosis in ER-negative breast cancer.T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers.Engineered reversal of drug resistance in cancer cells--metastases suppressor factors as change agents.Activation of ERα signaling differentially modulates IFN-γ induced HLA-class II expression in breast cancer cells.Tumor-infiltrating lymphocytes in breast cancer predict the response to chemotherapy and survival outcome: A meta-analysis.BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcomeStromal biomarkers in breast cancer development and progression.Adoptive immunotherapy of metastatic breast cancer: present and future.Mapping spatial heterogeneity in the tumor microenvironment: a new era for digital pathology.A novel non-parametric method for uncertainty evaluation of correlation-based molecular signatures: its application on PAM50 algorithm.Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.Beyond immune density: critical role of spatial heterogeneity in estrogen receptor-negative breast cancer.A role for T-lymphocytes in human breast cancer and in canine mammary tumorsQuantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling.Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers.APC downregulated 1 inhibits breast cancer cell invasion by inhibiting the canonical WNT signaling pathway.
P2860
Q26745444-01F95591-AB4E-43A3-8E55-442BF234B131Q28602995-9ABA4220-6E0B-4AE7-973C-A10A6B63684BQ30377226-7801BB53-3C2B-4731-8663-21A27D27B543Q30949620-A42986D2-14B3-4D42-81B2-235E74821CBDQ33669571-A2B4E84D-7D6C-4369-BF7D-303E40D7E883Q33738285-9F84BE83-79DD-49FE-9604-88D64785CC49Q33861620-FC96B037-78DE-4FDC-A2BC-4EA85D7494B3Q34427347-2DF9BE2F-711E-479E-8460-1599DA1D3439Q34613527-706EC614-6362-4929-8B3D-6D99613737DDQ34644894-154AAD1D-8A5C-4575-90DC-2F3DCC6A87BCQ35000238-5CB833E6-5F61-4584-A8F5-29161920DD3FQ35009369-4AAC4C16-4E81-4FE2-8077-7EB4BBDA3741Q35151735-5123E5B9-A0EA-4A51-900B-FEC131C8B10AQ35166659-7B8EE5AB-4634-4106-A58F-78A9FD3735F2Q35218520-8523D682-D82F-4580-87CC-C47469B18936Q35218681-F184D22E-F7BB-4F38-90A9-D4115120816EQ35588434-9A189292-A530-4149-A306-529F6B011146Q35683578-5707ED8C-341B-4530-8B84-FA794314CEACQ35769036-EDD3ABC4-4000-4F7C-B1B2-A63EFD8836A3Q35889643-42CEC613-94B7-4513-A3FF-D1EEE1ACA983Q36245546-21C12622-FEB5-4FCD-8AB1-D01F3C4677FAQ36253304-9CE501FC-93F7-42A3-8603-26BA5B09EDD0Q36557847-B5351160-8483-41AC-96D6-868C830EA146Q36955150-D2919938-1475-4C04-8CEF-50572FCF544BQ37128424-FE969BEC-2AF7-47A2-81DF-177B03306AADQ37208738-2F1180D8-ECD6-487A-A7DD-1F93BD47D204Q37518671-0767EC55-DA47-4B92-B6D8-E44F0615AD86Q37521175-64B56D8C-8830-4BA6-9272-7011C02E0DF0Q37536862-B0F45801-A500-4E09-A0DE-A8EA7A4AB7DEQ37689788-1001CA9C-D927-4BB2-9003-0B656D6B4980Q38017601-41DB3C3B-FC03-4FDE-AB16-F7D2B17E0B0EQ38171325-88ED979F-2D4D-4975-9284-35F381E5C345Q38323254-40920461-6105-4A52-A48C-268B8391C4A1Q39035017-1B21B993-E782-4857-B54B-653A961CBF67Q39592740-0FB2F2E4-9CF4-4076-B498-1AB421C32BEDQ41346864-999DBD92-4C92-4336-9B5E-C511E6302561Q41966647-3A374F4D-8E64-4F02-B97B-5EEE6C6A70AFQ44071623-5882AD2E-DFAD-4CF3-94FC-DCFE27EEA2A7Q45766039-2ECD0656-FFB4-4424-AB12-9E207DC9F805Q47108889-EA9EFC49-9498-40A6-B36C-EE698FC21B06
P2860
Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Effects of infiltrating lympho ...... nd prognosis in breast cancer.
@en
type
label
Effects of infiltrating lympho ...... nd prognosis in breast cancer.
@en
prefLabel
Effects of infiltrating lympho ...... nd prognosis in breast cancer.
@en
P2093
P50
P1476
Effects of infiltrating lympho ...... nd prognosis in breast cancer.
@en
P2093
Alberto Calabrò
Axel Benner
Ferdinand Ploner
Hellmut Samonigg
Martin Asslaber
Michael Stojanov
Ruprecht Kuner
Tim Beissbarth
P2888
P356
10.1007/S10549-008-0105-3
P407
P577
2008-07-01T00:00:00Z
P5875
P6179
1020647590